Add-On Prostaglandin E1 in Venovenous Extracorporeal Membrane Oxygenation: A Randomized, Double-Blind, Placebo-controlled Pilot Trial
Nina Buchtele(Medical University of Vienna), Thomas Staudinger(Northwestern University), Michael Schwameis(Medical University of Vienna), Harald Herkner(Medical University of Vienna), Oliver Robak(Medical University of Vienna), Andja Bojic(Comprehensive Cancer Center Vienna), Peter Schellongowski(Medical University of Vienna), Bernhard Nagler(Medical University of Vienna), Bernd Jilma(Medical University of Vienna), Katharina Riss(Comprehensive Cancer Center Vienna), Christian Schörgenhofer(Medical University of Vienna), Ludwig Traby(Medical University of Vienna), Monika Schmid(Medical University of Vienna), Alexander Hermann(Universitätszahnklinik Wien)
Cited by 16
Related Papers
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies
|The Lancet Infectious Diseases|2013|876
Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS
|Intensive Care Medicine|2013|603
Meta‐analysis: <scp>ARFI</scp> elastography versus transient elastography for the evaluation of liver fibrosis
|Liver International|2013|417
Symptoms of burnout in intensive care unit specialists facing the COVID-19 outbreak
|Annals of Intensive Care|2020|392
Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit
|Critical Care Medicine|2000|344